Nafarelin

Nafarelin
Nafarelin
Systematic (IUPAC) name
(2R)-N-[(2R)-5-carbamimidamido-1-[(2S)-2-[(carbamoylmethyl)carbamoyl]pyrrolidin-1-yl]-1-oxopentan-2-yl]-2-[(2R)-2-[(2R)-2-[(2R)-3-hydroxy-2-[(2S)-2-[(2S)-3-(1H-imidazol-4-yl)-2-{[(2R)-5-oxopyrrolidin-2-yl]formamido}propanamido]-3-(1H-indol-3-yl)propanamido]propanamido]-3-(4-hydroxyphenyl)propanamido]-3-(naphthalen-2-yl)propanamido]-4-methylpentanamide
Clinical data
Trade names Synarel
AHFS/Drugs.com monograph
MedlinePlus a601082
Pregnancy cat. X
Legal status ℞-only
Routes Nasal spray
Pharmacokinetic data
Half-life 2.6 to 4 hours
Excretion renal
Identifiers
CAS number 76932-56-4 YesY
ATC code H01CA02
PubChem CID 25077649
DrugBank APRD01129
ChemSpider 10482014 YesY
UNII 1X0094V6JV N
ChEMBL CHEMBL1201309 N
Chemical data
Formula C66H83N17O13 
Mol. mass 1321.6344 g/mol
 N(what is this?)  (verify)

Nafarelin is a gonadotropin-releasing hormone agonist (GnRH agonist). By causing constant stimulation of the pituitary, it decreases pituitary secretion of gonadotropins luteinizing hormone (LH) and follicle stimulating hormone (FSH). Nafarelin may be used in the treatment of estrogen-dependent conditions (such as endometriosis or uterine fibroids), to treat central precocious puberty, and to control ovarian stimulation in IVF.

It is normally delivered via a nasal spray.

Nafarelin acetate is marketed by Searle (now part of Pfizer) under the brand name Synarel.

Side effects

Side effects of nafarelin are mostly related to the low estrogen state. Side effects include hot flashes, vaginal dryness, headaches, mood changes, and decreased interest in sex. Some patients may experience acne, muscle pain, reduced breast size, and irritation of the tissue inside the nose. These side effects should disappear after stopping the medication.


Wikimedia Foundation. 2010.

Игры ⚽ Поможем написать реферат

Look at other dictionaries:

  • nafarelin acetate — naf·a·rel·in ace·tate (nafґə rel″in) a synthetic preparation of gonadotropin releasing hormone, used in the treatment of central precocious puberty and of endometriosis; administered by nasal spray …   Medical dictionary

  • Cetrorelix — Systematic (IUPAC) name Acetyl D 3 (2´ naphtyl) alanine D 4 chlorophenylalanine D 3 (3´ pyridyl) alanine L serine L tyrosine D citruline L leucine L arginine L proline D alanine amide Clinical da …   Wikipedia

  • Эндометриоз — МКБ 10 N …   Википедия

  • Oxytocin — Systematic (IUPAC) name 1 ({(4R,7S,10S …   Wikipedia

  • Cryptorchidism — Classification and external resources ICD 10 Q53 …   Wikipedia

  • Desmopressin — Systematic (IUPAC) name (2S) N [(2R) 1 [(2 amino 2 oxoethyl)amino] 5 (diaminomethylideneamino) 1 oxopentan 2 yl] 1 [(4R,7S,10S,13S,16S) 7 (2 amino 2 oxoethyl) 10 (3 amino 3 oxopropyl) 16 [(4 hydroxyphenyl) …   Wikipedia

  • ATC code H01 — A section of the Anatomical Therapeutic Chemical Classification System.H Systemic hormonal preparations, excluding sex hormones and insulinsH01A Anterior pituitary lobe hormones and analoguesH01AA Adrenocorticotropic hormone:H01AA01 Corticotropin …   Wikipedia

  • Conivaptan — Systematic (IUPAC) name N (4 (4,5 dihydro 2 methylimidazo[4,5 d][1]benzazepin 6(1H) yl)carbonyl)phenyl) (1,1 biphenyl) 2 carboxamide Clinical data …   Wikipedia

  • Octreotide — Systematic (IUPAC) name (4R,7S,10S,13R,16S …   Wikipedia

  • Felypressin — IUPAC name 1 [19 Amino 13,16 dibenzyl 10 (2 carbamoyl ethyl) 7 carbamoylmethyl 6,9,12,15,18 pentaoxo 1,2 dithia 5,8,11,14,17 pentaaz …   Wikipedia

Share the article and excerpts

Direct link
Do a right-click on the link above
and select “Copy Link”